Commerce Bank Acquires New Holdings in Smith & Nephew SNATS, Inc. $SNN

Commerce Bank bought a new position in shares of Smith & Nephew SNATS, Inc. (NYSE:SNN) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 61,916 shares of the medical equipment provider’s stock, valued at approximately $3,883,000.

Several other hedge funds have also recently bought and sold shares of SNN. Northwestern Mutual Wealth Management Co. bought a new position in Smith & Nephew SNATS in the second quarter valued at approximately $840,000. Quantbot Technologies LP bought a new stake in shares of Smith & Nephew SNATS during the second quarter worth $6,342,000. Evolve Private Wealth LLC bought a new stake in shares of Smith & Nephew SNATS during the second quarter worth $364,000. Landscape Capital Management L.L.C. acquired a new stake in shares of Smith & Nephew SNATS during the second quarter worth $1,090,000. Finally, EP Wealth Advisors LLC acquired a new stake in shares of Smith & Nephew SNATS during the second quarter worth $398,000. 25.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Sanford C. Bernstein set a $31.85 target price on shares of Smith & Nephew SNATS in a research note on Monday, May 11th. Morgan Stanley reissued an “overweight” rating on shares of Smith & Nephew SNATS in a research note on Wednesday, August 5th. Barclays lowered Smith & Nephew SNATS from an “equal weight” rating to an “underweight” rating in a report on Wednesday, August 5th. Zacks Research downgraded Smith & Nephew SNATS from a “hold” rating to a “strong sell” rating in a report on Friday, August 7th. Finally, Canaccord Genuity Group dropped their target price on Smith & Nephew SNATS from $32.00 to $30.00 and set a “hold” rating on the stock in a research report on Monday, May 11th. Two equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $30.93.

Smith & Nephew SNATS Stock Performance

Shares of SNN opened at $29.64 on Tuesday. Smith & Nephew SNATS, Inc. has a 12 month low of $28.56 and a 12 month high of $38.79. The firm has a fifty day simple moving average of $30.30 and a 200 day simple moving average of $31.82. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.11 and a current ratio of 2.14.

Smith & Nephew SNATS Dividend Announcement

The firm also recently declared a dividend, which will be paid on Friday, November 6th. Shareholders of record on Friday, October 2nd will be given a dividend of $0.312 per share. The ex-dividend date of this dividend is Friday, October 2nd. This represents a yield of 205.0%.

About Smith & Nephew SNATS

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.